Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

Aghajanian, Carol

Phase II trial of bevacizumab in recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun 2011 - 2259-65 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2010.32.6397 doi


Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Bevacizumab
Disease-Free Survival
Endometrial Neoplasms--drug therapy
Female
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Salvage Therapy--methods
Vascular Endothelial Growth Factor A--biosynthesis